000			01966 a2200505 4500
005			20250517194813.0
264		0	_c20180831
008			201808s 0 0 eng d
022			_a1791-2423
024	7		_a10.3892/ijo.2018.4244 _2doi
040			_aNLM _beng _cNLM
100	1		_aYou, Kyu Sic
245	0	0	_aInhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells. _h[electronic resource]
260			_bInternational journal of oncology _cMar 2018
300			_a828-840 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDown-Regulation
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aDrug Synergism
650	0	4	_aErbB Receptors _xantagonists & inhibitors
650	0	4	_aFemale
650	0	4	_aGefitinib
650	0	4	_aGene Knockdown Techniques
650	0	4	_aHeterocyclic Compounds, 3-Ring _xpharmacology
650	0	4	_aHumans
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors
650	0	4	_aQuinazolines _xpharmacology
650	0	4	_aRNA, Small Interfering _xmetabolism
650	0	4	_aRegulatory-Associated Protein of mTOR _xgenetics
650	0	4	_aRibosomal Protein S6 _xmetabolism
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTOR Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aTriple Negative Breast Neoplasms _xdrug therapy
700	1		_aYi, Yong Weon
700	1		_aKwak, Sahng-June
700	1		_aSeong, Yeon-Sun
773	0		_tInternational journal of oncology _gvol. 52 _gno. 3 _gp. 828-840
856	4	0	_uhttps://doi.org/10.3892/ijo.2018.4244 _zAvailable from publisher's website
999			_c27990271 _d27990271